uterine fibroid. Leiomyoma of uterus
Conditions
Interventions
Participants in the intervention group will receive the Razak Curcumin capsule at a dose of 370mg three times a day for 3 months..
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Patients with the age between 18 - 55 years old are included. Patients with an established diagnosis of uterine leiomyoma are included. Patients with leiomyoma sized between 1 to 10 cm are included. Patients with no severe symptoms are included. Patients without severe anemia which necessitate transfusion, are included. Patients without mass effect symptoms are included. Patients with no history of hydronephrosis are included. Patients with no history of malignancy are included. Patients with no history of coagulation problems are included. Patients with no history of gastrointestinal diseases are included. Patients with no history of renal diseases are included. Patients without diabetes mellitus are included. Patients who do not consume any anticoagulant and anti-inflammatory medications are included. Patients who are not pregnant are included. Patients who are not breastfeeding are included. Patients with no history of other gynecological problems such as adenomyosis or endometriosis are included. Patients with no allergy to curcumin are included. Patients who are willing to participate in the study are included.
Exclusion criteria
Exclusion criteria: Patients who have allergy to curcumin are excluded. Patients who do not want to participate in the study or continue are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Persian version of Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) questionnaire score. Timepoint: 3 months from the beginning of the intervention. Method of measurement: Persian version of Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) questionnaire.;Size of leiomyomas. Timepoint: 3 months from the beginning of the intervention. Method of measurement: ultrasound evaluation.;Hemoglobin level. Timepoint: 3 months from the beginning of the intervention. Method of measurement: laboratory test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNiki Talebian
Shahid Beheshti University of Medical Sciences
Outcome results
None listed